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Summary 
We show here that cell sorter purified JORO 75 + lymphocyte progenitors from fetal liver or 
bone marrow of adult mice give rise in vitro to CD4 + 8-  T  cell receptor (TCR)/CD3-  early 
thymocytes  and  CD4+8 -  TCR/CD3 +  thymocyte  subsets  after  coculture  with  the  EH6 
subcapsular thymic epithelial cell line,  recombinant  interleukin  7 (rlL-7)  and F  (supernatants 
from the FLS4.1 fetal liver stromal cell line). We find that in cultures that had additionally received 
rlL-2, CD4-8 + TCR/CD3 + cells were also generated.  The results strongly suggest that fetal 
liver  and  marrow JORO  75 +  lymphocyte progenitors  are precursors  to  the  early CD4+8 - 
TCR/CD3-  intrathymic  population  previously  identified  in  the  adult  mouse.  The  EH6 
subcapsular thymic epithelial  cell line should facilitate the study of the molecular events responsible 
for very early stages of T  cell development including  T  lymphocyte-lineage commitment. 
ecent studies by Wu et al. (1, 2) report on the identification 
in the thymus of adult mice of a minute cell popula- 
tion that expressed low levels of CD4 on the ceU membrane 
and could give rise to more mature thymocyte subsets after 
intrathymic  transfer to irradiated  animals.  The authors re- 
ferred to this subset as the earliest intrathymic precursor cells 
in the adult  thymus or as the low CD4 precursor  (1,  2). 
Previously we have described the characterization  of the 
mAbs JORO 37-5 and JORO  75, which mark very early 
T cell progenitors present in the liver and thymus of the de- 
veloping embryo and the bone marrow of young adult mice 
(3, 4). JORO + cells are very rare in the adult thymus, but 
they colonize this organ both in the embryo and in adult 
mice, expand, and give rise to cr  and ~/3' T lymphocytes 
(3, 4). The genes encoding JORO 37-5 and JORO 75 sur- 
face makers have no significant sequence similarity to any pre- 
viously described gene that has been reported in the EMBL 
and the GenBank data bases (Palacios, R., manuscript in prep- 
aration). 
We wished to determine whether a precursor-product rela- 
tionship existed between JORO + fetal liver or adult bone 
marrow lymphocyte progenitors and the low CD4 thymo- 
cyte precursor cells. Neither we nor Shortman's group have 
found expression of JORO 75 or JORO 37-5 on the low 
CD4 thymocyte subset (our unpublished results). In the ex- 
periments  described  here,  we  tested  the  hypothesis  that 
JORO + cells are precursors of low CD4 early thymocytes. 
Materials  and Methods 
Mice.  C57BL/6 young adult mice were bred and maintained 
in our animal facilities. Embryos were obtained from C57BL/6 timed 
matings. The day of detection of a vaginal plug was designated day 0. 
Separation of Cells.  Bone marrow mononudear cells from young 
adult mice and fetal fiver mononuclear  cells from day 14-15 em- 
bryos were prepared as described before (3, 4). JORO 75 + lym- 
phocyte progenitors were isolated and purified by a negative selec- 
tion step using a magnetic beads procedure followed by a positive 
selection step by cell sorting (Elite V; Coulter, Miami, FL) using 
biotin-labeled JORO 75 antibody and PE-streptavidin as described 
in detail before (5). Upon reanalysis, between 98.5 and 99.4% 
fetal liver cells and between 98.1 and 99.0% marrow ceils were 
JORO +. The recovery was usually 0.3-0.5% from fetal liver cells 
and 0.1-0.4% from adult  bone marrow.  The cells were washed 
and resuspended in IMDM (GIBCO BILL, Gaithersburg,  MD), 
7.5% FCS (Hyclone Laboratories, Logan, UT), 2 ram t-glutamine, 
5  x  10 -s M 2-ME, and 50 #g/ml gentamycin (GIBCO BILL). 
Cell Lines and Cytokines.  The EH6 subcapsular thymic epithe- 
lial cell line was obtained  from newborn (C57BL/6  x  CBA)F1 
mice by the procedure described earlier (6). These cells are mor- 
phologically and phenotypically different from cortical (e.g., ET, 
EA2) and medullary (e.g., EB3) tbymic epithelial cells. They ex- 
press cytokeratin and are positive for the NLDC-145 marker present 
on subeapsular epithelial and dendritic cells and negative for markers 
of cortical (ER-TR4, 4F1) or medullary (EK-TR5, IVC4) epithe- 
lial cells, fibroblasts (ER-TR7), myeloid cells (8C5, F4/80, Mac-l, 
BP-2, Mac-2, Mac-3), and lymphoid cells (JORO 75, JOR.O 37-5, 
B-220, IgM, CD4, CD8, CD3) (7-10). EH6 are nontransformed 
cells in that they do not form tumors in immunocompromised mice. 
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fected with mouse IL-7 cDNA (11); rlL-2 and rlL-3 were superna- 
tants from X63 Ag8 myeloma cells transfected with mouse I1.-2 
or II.-3 cDNA (12). The cytokine preparations were tested for bio- 
logical activity in proliferative assays as described  (11). Superna- 
tants collected from confluent cultures  of the FLS4-1  fetal liver 
stromal cell line (13) will be referred to as F  (for factor). 
Antibodies.  The following antibodies were used in FACS  |  anal- 
ysis: biotin-labeled JORO 75 or JORO37-5; FITC or biotin CD3 
(145-2Cll); FITC or PE-conjugated  CD8 (53672) and CD4 (GK1.5, 
H129); FITC- or biotin-labeled TCR-oe/t5 (H57197)  or TCR-8/'y 
(gL3); biotin  CD44  (PgP-1,  142/5);  and FITC or biotin  Mac-1 
(M1/60). 
FACS  |  Analysis.  FACS  |  analysis was carried out as described 
before (3,  11) with the exception that a Coulter profile and Elite 
V  machines were used.  All stainings were done in  the presence 
of purified rat IgG (250/~g/ml) and heat-inactivated hamster serum 
(15%) to prevent nonspecific  Fc-receptor binding of labeled anti- 
bodies. Mononuclear cells from thymus, spleen, or fetal liver were 
used as positive controls as required.  Cells stained with rat IgG 
and FITC or PE-streptavidin were used  as negative control. 
Cell Culture Assay.  Six-well plates (Costar Corp., Cambridge, 
MA) containing monolayers of EH6 subcapsular thymic epithelial 
cells ('-50% conftuency) received fetal liver or adult bone marrow 
purified JORO 75 + cells (5  x  104 cells/well)  and culture medium 
supplemented with rlL-7  (250-500  U/ml),  F (10% vol/vol final 
concentration), and in some experiments rlL-2 (50-100 U/ml) or 
rib3  (50-200 U/ml) in a final volume of 2 ml/per well. At day 
5-6  of culture,  1  ml  of fresh  culture  medium  containing  the 
cytokines indicated above was added to each well. Cells were har- 
vested, washed, and tested by FACS  |  analysis for the presence of 
several T  cell lineage surface  markers. 
Results and Discussion 
In the course of experiments assessing the functional prop- 
erties of the EH6 thymic subcapsular epithelial cell line, we 
found that these cells in the presence of rlL-7 and F (super- 
natants  from the FLS4.1  fetal liver  stromal line,  which  se- 
crete Steel Factor and another factor that supports the forma- 
tion of T cell progenitors and the proliferation of hematopoietic 
stem cells)  supported  the differentiation  of purified JORO 
75 + fetal liver cells along the T  cell pathway. Indeed, JORO 
75 + lymphocyte progenitors  gave rise,  under  these culture 
conditions,  to  CD4+8 -  TCR/CD3-  immature  and  to 
fewer  CD4 +  8-  TCR/CD3*  and  CD4- 8-  TCR/CD3 § 
mature cells. No CD8 §  or CD4+8 + cells were detected in 
these cultures. Only some of the cells in the cultures remained 
JORO  75 + or JORO37-5 +, which is consistent with their 
differentiation into thymocytes, and most cells were PgP-1 + 
(Fig.  1 B and Table 1). JORO  75 + fetal liver cells before in- 
duction were CD4-8-  TCR/CD3-  PgP-1 + (Fig.  1 A  and 
data not shown).  Similar results were obtained in the other 
three experiments we carried out (Table 1). These data show 
that  JORO  75 +  fetal  liver  progenitors  are  precursors  to 
CD4 +8-  TCR/CD3-  immature  and  CD4 + 8-  TCR/ 
CD3 +,  CD4- 8- TCR/CD3 §  mature  thymocytes. 
We thought it would be interesting to test whether JORO 
75 § progenitors from the bone marrow of adult mice would 
exhibit  a similar potential  to that of JORO  75 + fetal liver 
progenitors.  The results of such experiments  are illustrated 
in the form of contour plots in Fig.  1 and are summarized 
in  Table  1.  Bone marrow-purified JORO  75 + progenitors 
cultured  on EH6  subcapsular  thymic epithelial  ceils,  rlL-7 
and F, also gave rise to CD4+8 -  TCR/CD3  , and to fewer 
CD4 + 8-  TCR/CD3 +  and  CD4- 8-  TCR/CD3 §  cells 
(Fig.  1 D).  Purified JORO  75 § marrow progenitors before 
induction  were  CD4-8-  TCR/CD3-  PgP-1 §  (Fig.  1  C 
and  data  not  shown).  The  CD3 +  cells  comprised  both 
cr/13 + and 6/3  '+ cell lineages that were present at ratios that 
varied from experiment  to experiment.  Thus, JORO  75 § 
progenitors  from either  14-15 day fetal liver or adult bone 
marrow are precursors to CD4 + 8-  TCR/CD3-  immature 
and  to  more mature  thymocyte subsets  (see below). 
Whereas the culture condition described above seems very 
useful to the study of early events after interactions between 
T  cell progenitors and subcapsular thymic epithelium, it ob- 
viously cannot replace the thymic microenvironment. Because 
we have previously shown that there is functional heteroge- 
neity of thymic epithelial cells in promoting differentiation 
of PRO-T cells into the different thymocyte subsets (6,  14), 
we were not surprised that not all thymocyte subsets devel- 
oped in the cultures.  Notwithstanding  these considerations, 
we thought that the EH6 cell-based induction assay also could 
be used to test the effects of soluble cytokines on the develop- 
mental potential of JORO  75 + lymphocyte progenitors.  To 
our surprise, we found that the addition of rlL-2 to the cul- 
tures  promoted  the  generation  of  CD8+4 -  and  some 
CD4+8 +  thymocyte  subsets,  as  well  as  the  CD4+8 - 
TCR/CD3-,  CD4 § 8-  TCR/CD3 +  and CD4- 8-  TCR/ 
CD3 + populations  that were seen in cultures  incubated  in 
the absence of rlL-2 (Fig.  1, E  and G; Table 1).  In contrast, 
rlL-3 added to similar cultures increased the number of cells 
recovered at the end of the cultures, but did not significantly 
change the thymocyte populations  generated by either fetal 
liver or adult marrow JORO  75 + progenitors in the absence 
of rlL-3 (Fig.  1, F  and H; Table 1). The results suggest that 
rlL-2 influences the developmental potential of JORO  75 + 
lymphocyte  progenitors  and  promotes  the  formation  of 
CD8 §  thymocytes.  These  data  are  consistent  with  earlier 
studies (15-18) using quite different assays that have pinpointed 
a role for IL-2 in thymocyte development.  They are appar- 
ently at odds with the information obtained in IL-2-deficient 
mutant mice, which showed quasi-normal thymocyte devel- 
opment (19). However, we believe that the latter could very 
well reflect the action of another cytokine (e.g.,  IL-4) that 
compensates for the deficiency of IL-2 in the mutant  mice. 
Such  compensatory or redundant  cytokine function  is cer- 
Figure  1.  JORO 75 + progenitors from day 14-15 fetal liver (A, B, E. and F) or adult bone marrow (C, D, G, and H) were cultured on monolayers 
of EH6 subcapsular thymic epithelial cells in the presence of rlL-7 and F without (B and D) or with rlL-2 (E and G) or rlL-3 (F and/4). A and C 
are from uninduced JORO 75 + progenitors from fetal liver (A) and adult marrow (C), respectively. After 6-8 d in culture, the presence of cells posi- 
tive for the surface markers indicated was determined by two-color FACS  |  analysis. 
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Precursor cells 
(induction  assay) 
Cell 
Percent positive  cells FACS  |  analysis 
recovery CD4+8 - CD4+8 - CD4-8 + CD4-8 § CD4-8- 
x 106  CD3-  CD3 +  CD3-  CD3 §  CD3 +  CD4+8 + JORO 75 + JORO 37-5*  PgP-1 + 
JORO 75 + F.  liver 
EH6 + IL-7 + F 
Exp.  1  2.4  20.3  3.4  0.1  0.2  1.7  0.3  26.8  28.4  99.2 
Exp.  2  3.1  32.9  13.5  0.1  0.3  0.7  0.7  28.6  31.7  97.1 
Exp.  3  2.6  15.4  4.6  0.1  0.2  1.6  0.2  24.4  24.9  99.5 
EH6 + IL-7 + F + IL-2 
Exp.  1  2.8  11.4  9.8  2.9  7.8  7.5  1.9  11.7  14.5  99.6 
Exp.  2  3.9  17.7  21.4  5.8  12.7  8.2  3.1  10.0  10.9  98.5 
EH6 + IL-7 + F + IL-3 
Exp.  1  4.7  13.5  2.0  0.2  0.3  1.7  0.5  35.7  37.4  98.6 
Exp.  2  5.2  19.6  5.3  0.1  0.3  1.1  0.3  41.0  40~2  99.1 
JOgO  75 § adult bone marrow 
EH6 + IL-7 + F 
Exp.  1  1.7  8.3  1.4  0.1  0.2  2.0  0.2  25.5  27.0  98.5 
Exp.  2  2.2  16.9  3.3  0.1  0.3  1.0  2.7  31.4  31.8  99.7 
EH6 + IL-7 + F + IL-2 
Exp.  1  2.5  9.9  14.5  3.6  8.9  4.2  1.6  12.7  14.9  97.5 
Exp.  2  2.9  8.1  22.0  6.5  16.6  4.6  6.5  10.0  11.4  98.8 
Cell sorter purified JOKO 75 + progenitor cells were cocultured with EH6 subcapsular thymic epithelial cells, rIL-7, and F in the presence or ab- 
sence of rlL-2 or rIL-3 at 37~  for 6-8 d. The presence of cells positive for the surface markers indicated above  was assessed by two-color FACS  ~  analysis. 
Number of viable cells recovered per plate at the end of the culture. Input ceUs in all cultures were 3  x  10  s per plate. 
tainly much more limited in the in vitro system described 
here. An alternative interpretation of these results is that IL-2 
added to the cultures could have supported the expansion of 
few CD8 + cells that were generated in the cultures.  In this 
scenario, IL-2 would merely expand (not induce the devel- 
opment) CD8 +, and thereby increase the frequency of these 
cells to levels readily detectable by FAC,  S  ~ analysis. The slightly 
increased numbers of cells recovered in cultures supplemented 
with IL-2 compared with those found in cultures without 
exogenous IL-2 (Table 1) would tend to support this latter 
view. 
In conclusion, the experiments described here provide evi- 
dence that JORO 75 + lymphocyte progenitors  in the fetal 
liver  and in the adult  bone marrow give rise in vitro  to 
CD4+8 -  TCR/CD3-  early thymocytes.  The EH6 subcap- 
sular thymic epithdial cell line should help us to elucidate 
the molecular  events responsible  for very early stages of T 
cell development, including T lymphocyte lineage commit- 
ment and determine the role of cytokines in such a process. 
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